Donald R Parfet
CIK 1305641 · Chairman of the Board · last filed 2026-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.36M
Companies
6
Total Filings
96
Lifetime Open-Market Net
-$1.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROK | Director | 14,014 | $471.17 | $6.60M | -$1.27M | 42 | 2026-02-11 |
| MAS | Director | 5,574 | $81.61 | $454.9K | -$428.9K | 22 | 2024-08-05 |
| KELYB | Director | 100,296 | $23.18 | $2.33M | $53.4K | 22 | 2024-05-10 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 1,946 | $54.99 | $107.0K | $0 | 4 | 2019-06-12 |
| Sierra Oncology, Inc. (DNAI) Delisted | Chairman of the Board | 76,444 | — | — | $0 | 5 | 2016-11-10 |
| UNM | Director | 33,835 | $87.93 | $2.98M | $0 | 1 | 2013-05-10 |
Recent Filings · Page 5 of 10
96 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-28 | ROK | Will (W) | +17 | $0 | EDGAR |
| 2018-06-14 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-15 | MAS | Grant (A) | +3,680 | $0 | EDGAR |
| 2018-05-10 | KELYB | Grant (A) | +3,577 | $110.0K | EDGAR |
| 2018-02-07 | ROK | Grant (A) | +213 | $0 | EDGAR |
| 2018-01-08 | Sierra Oncology, Inc. (SRRA) Delisted | Other (J) | +4,763 | $0 | EDGAR |
| 2017-10-03 | ROK | Grant (A) | +512 | $0 | EDGAR |
| 2017-06-14 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-12 | KELYB | Sell (S) | −22,029 | -$508.9K | EDGAR |
| 2017-05-16 | MAS | Grant (A) | +3,570 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.